Kate Therapeutics

Kate Therapeutics is a patient-focused biotechnology company that develops AAV-based gene therapies to treat inherited muscle and heart diseases. The company is applying a new technology platform to directly address key limitations of current gene therapies, including tissue-specific delivery and gene regulation. These breakthroughs have the potential to enhance the efficacy and safety of gene therapies and enable the pursuit of a broader range of targets that are otherwise difficult to drug with existing technologies.